225
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Self-reported efficacy of neurofeedback treatment in a clinical randomized controlled study of ADHD children and adolescents

, &
Pages 1645-1654 | Published online: 02 Sep 2014

Abstract

Background

Many non-pharmacological treatments for children and adolescents with attention-deficit/hyperactivity disorder (ADHD) have been attempted, but reports indicate that most are ineffective. Although neurofeedback (NF) is a treatment approach for children with ADHD that remains promising, a variety of appropriate measures have been used in reporting and evaluating its effect.

Objective

To report the self-evaluations of NF treatment by children and adolescents with ADHD.

Methods

Randomized controlled trial in 91 children and adolescents with ADHD, aged less than 18 years (mean, 11.2 years) participated in a 30-session program of intensive NF treatment. Participants were randomized and allocated by sequentially numbered sealed envelopes into three groups: methylphenidate (MPH) as an active control group, and two trial groups NF with MPH, and NF alone. ADHD core symptoms and school performance were given on a scale of 1 to 10 using a self-reporting questionnaire, and the changes in these scores after treatment were used as the self-reported evaluation. Basic statistical methods (descriptive, analyses of variance, exact χ2 test, and paired t-test) were used to investigate the baseline data. Changes in ADHD core symptoms and treatment effects were investigated using a general linear model for repeated measures.

Results

Eighty participants completed the treatment study and 73 (91%) responded sufficiently on the self-reporting questionnaires. The treatment groups were comparable in age, sex, and cognition as well as in the baseline levels of core ADHD symptoms. All treatments resulted in significant improvements regarding attention and hyperactivity (P<0.001), and did not differ from each other in effectiveness. However, a significant treatment effect in school performance was observed (P=0.042), in which only the NF group showed a significant improvement.

Conclusion

The self-reported improvements in ADHD core symptoms and school performance shortly after treatment indicate NF treatment being promising in comparison with medication, suggesting NF as an alternative treatment for children and adolescents who do not respond to MPH, or who suffer side effects. Further long-term follow-up is needed.

Introduction

Attention-deficit/hyperactivity disorder (ADHD) is a serious health problem, and adequate multimodal treatment is necessary to avoid development of behavior problems, academic impairment, social dysfunction, and poor self-esteem.Citation1 Almost one in four children do not respond sufficiently to central stimulation treatment,Citation2 and ADHD symptoms can continue after psychopharmacological treatment has been withdrawn.Citation3 Alternative treatments are therefore continuously being sought.

Recently, neurofeedback (NF) has been proposed as a treatment for ADHD that improves attention and decreases hyperactivity symptoms.Citation4Citation8 NF is an electroencephalographic (EEG) operant-conditioning training technique that helps individuals to alter their brain activity.Citation9 It is a kind of behavioral therapy aimed at developing skills for self-regulation of cortical activity.Citation10,Citation11 This method uses real-time EEG displays to develop skills which regulate brain activity.Citation11Citation13 NF is aiming to normalize the EEG by improving cortical functioning.Citation14 The patient learns to enhance the EEG desired frequencies and suppress the undesired ones in the form of a rewards system.Citation15 This may affect for example attention, or other neurocognitive processes.Citation16

In mostly uncontrolled and non-randomized studies NF has been shown to provide therapeutic benefits to patients with ADHD.Citation7,Citation8,Citation17 A meta-analysis by Arns et al and Lofthouse et al reviewed randomized and non-randomized, published and unpublished trials and illustrated that some studies are limited by incomplete randomization (even randomized trials), small sample size, semi-active control groups, and no placebo and that more randomized, placebo control studies are needed.Citation18,Citation19 Lately, randomized studies from Duric et al and Meisel et al found promising evidence of ADHD symptom improvements in treatment with NF.Citation20,Citation21 Significant improvements of ADHD symptoms over time after NF treatment were found in a double-blind placebo feedback-controlled design by Lansbergen et al.Citation22 Recently, Sonuga-Barke et al suggested in a review of randomized controlled trials, alternative treatment of ADHD including NF and suggested that better evidence for efficacy of NF is required with blinded assessments.Citation23

While NF has been reported to improve core ADHD symptoms, increase self-esteem,Citation3,Citation4,Citation8 and improve learning,Citation9 the mechanism of action still remains unknown. However, it is important to explore the effect by self-reporting as well. For adults few self-report studies have indicated that NF is comparable to treatment with stimulant medication.Citation24Citation26

Using self-report in studies of children and adolescents with ADHD has been poor, with inconsistent and divisive results.Citation25,Citation27 The validity of health-quality reports is much greater when individuals report their own perceptions.Citation28 The reliability of self-reports and the ability of teachers, parents, and key workers to assess ADHD symptoms have been questioned.Citation26 Although parent reports differ from those of children, the child has valuable awareness of own experiences, especially for medical history, behavior, and health care.Citation26,Citation29 While some studies of children with ADHD suggest that despite functional problems in areas such as academics and development, self-reports tend to under-report the presence of symptoms,Citation30,Citation31 other studies indicate that they describe their difficulties adequately.Citation30,Citation31 Among self-report studies, those that have used NF are virtually nonexistent, although reports from parents and teachers do exist.Citation32

One of the most basic reasons for investing resources in child self-report health data is that parents appear as proxy respondents and their reports correlate poorly with those of their children, which is a reason often cited for not assessing children directly. Despite the increasing acceptance of adolescents’ self-reports, their concordance with reports from their parents is not any better than that of parents and children.Citation33,Citation34 In the present study we wanted to explore self-reported efficacy of NF treatment in a clinical, randomized, and controlled study of ADHD children and adolescents.

Methods

Randomized controlled trial NCT01252446

Subjects and randomization

Children and adolescents with ADHD (aged under 18 years) who were diagnosed with ADHD according to the International Statistical Classification of Diseases and Related Health Problems Tenth Revision (ICD-10) at the Child and Adolescent Mental Health Clinic, Fonna Trust, Haugesund, Norway, from 2007 to 2009, were invited to participate in the study.Citation32,Citation35,Citation36 One hundred and thirty participants with ADHD were randomly assigned to one of three groups: 1) a group treated only with methylphenidate (MPH) defined as active control group, and two experimental groups; 2) a group treated with NF and MPH (NF/MPH group), and 3) a group treated with NF (NF group). Randomization was performed using a random list with arbitrary numbers (0–1–2) in order to make three groups. No stratification regarding age, sex, or IQ was done.

Cognitive performance was assessed before starting treatment using the Wechsler Intelligence Scale for Children Revised edition (WISC-R).Citation37 Subjects in the MPH and NF/MPH groups were administered MPH twice per day, at the recommended dose of 1 mg/kg, with total daily dosages ranging from 20 to 60 mg.

The Regional Ethics Committee on Medical Research approved the project protocol, and written consent was obtained from all of the children or parents.

ADHD

The population of Norwegian children who were referred for ADHD treatment during the 3 year period has been described in earlier publications.Citation35,Citation36 The children underwent diagnostic assessment to confirm the diagnosis of ADHD. In short, assessment included a clinical psychiatric interview and observations to assess ADHD and other appropriate diagnoses. Questionnaires regarding ADHD were filled out by the children, parents, and teachers of the children. A medical examination was done to exclude somatic conditions causing ADHD symptoms. A child psychiatrist evaluated the assessments and categorized the children as having ADHD or a non-ADHD condition according to ICD-10 diagnostic criteria.Citation38

Treatment groups

The 130 participants with confirmed consent were randomly allocated by a coordinator into three groups: 1) the MED group, those treated with psychostimulant medication (MPH), 2) the NF + MED group, those treated with both NF and medication (MPH), and 3) the NF group, those only treated with NF.

Neurofeedback

Each participant was provided with 30 NF treatments for the duration of the study. Three sessions per week were conducted. The duration of each session was 45 minutes where each session started with 5 minutes of relaxation using alpha enhancement feedback, followed by two training sessions of twenty minutes each.

The system used for the recording was a Procomp Infinity from Thought Technology Ltd. (Montreal, QC, Canada) running Biograph Infinity software. This system is an eight channel, multi-modality encoder that is flexible, and designed for both clinical and research settings. The first two sensor channels provide ultimate signal fidelity (2,048 samples/s) for viewing raw EEG, electromyography (EMG), and electrocardiography (EKG) signals, and the remaining six channels (256 samples/s) can be used in combination with a variety of sensors such as EEG, EKG, EMG, skin conductance, heart rate, blood volume, pulse, and respiration. The system has an application suite which is a grouping of screens, computations, and protocols to be custom tailored to a user’s particular needs.

The NF training was based on the standard theta/beta protocol in Cz for ADHD treatments from Lubar (Association for Applied Psychophysiology and Biofeedback).Citation39,Citation40 In this protocol beta activity (16–20 Hz) is enhanced and theta (4–7 Hz) is suppressed.

In order to attach the electrodes to the scalp and ensure minimum impedance skin preparation was done with conductive Nuprep EEG skin gel (Weaver and Company, Aurora, CO, USA).Citation41 The electrode placement was at Cz (based on the 10–20 system of electrode placement) for all patients referenced to an ear (unipolar derivation). During the NF session, brain activity was shown to the participant using visual and auditory feedback.

For the training theta activity was defined as 4–7 Hz, beta activity as 15–20 Hz. EMG activity, defined as 80–150 Hz, was also monitored. The goal was to decrease theta activity by inhibiting high amplitude theta activity and by simultaneously rewarding high amplitude beta activity. Successful treatment was defined as a significant increase in beta activity, and a decrease in theta and EMG activities. Rewards were given if participants could keep theta levels below threshold 70% of the treatment time and keep beta levels above threshold 20% of the time. Depending on the participant’s performance these reward thresholds were manually adjusted by the therapist. In addition, the therapist verbally reinforced the participant’s performance and helped with progress.

After each session, the therapist and participant discussed the session in order to enhance motivation and engagement for further treatment.

Self-reporting questionnaire (SRQ)

Due to the nature of ADHD, the number of questions in an SRQ was limited to ensure that each child would be able to complete the questionnaire. So for this study we developed an SRQ, with questions derived from other questionnaires, including the Self-rating Scale of Self-regulatory FunctionCitation27 and the Piers-Harris Children’s Self-Concept Scale.Citation42 The SRQ consisted of five single items, two concerning ADHD core symptoms (inattention, hyperactivity) and three regarding school performance (mathematics, reading, and writing skills); school performance was defined as the sum of the three items (Supplementary materials).

The children were asked how they would rate themselves on a scale of 1–10 with regard to inattention, hyperactivity, and school performance. The SRQ was assessed at different time points (T1, T2). The pre-treatment (T1) SRQ was assessed just before beginning the NF therapy, and the post-treatment (T2) SRQ was completed approximately 1 week after completing the therapy. The self-reported evaluation of treatment was thus calculated as the change in score from period T1 to T2 (T2–T1).

Statistical analyses

Basic statistical methods (descriptive, analyses of variance [ANOVA], exact χ2 test, paired t-test) were used to investigate the baseline data.

The pre–post changes as well as the treatment effects were investigated using a general linear model (GLM) for repeated measures, which was implemented for each subscale (inattention, hyperactivity, and school performance). The model included the raw scores at both time points as dependent variables and the treatment groups as independent factors. In the GLM, we tested both pre–post changes in the ratings as well as treatment effects (differences between the treatments). Significance of differences between the treatments was further examined using post hoc tests. Additionally, we estimated the standardized effect size ES δRM according to Morris and DeShon for each treatment change.Citation43

The general significance level was set to 0.05. For the baseline investigation, we had to take into account the effects of multiple comparisons. However, we decided to set the significance level to 0.01, as a compromise between a Bonferroni correction and not accounting for multiple comparisons. In the GLM, we investigated only highly correlated variables, thereby reducing the number of comparisons. Therefore, we did not adjust the significance level. A correlation between self-report and parents’ report was performed. All computations were done using SPSS 21 (IBM Corporation, Armonk, NY, USA).

Results

Subjects

Of 130 randomized participants 91 completed the treatment, but only 80 participants agreed to fill out the SRQ (). However, three did not answer the SRQ for attention and hyperactivity (questions 1 and 2), and a further four participants did not complete the SRQ for school performance (question 3 to 5). The mean age for the 80 participants was 11.2±2.8 years, and the majority of participants were boys (81%).

Table 1 Comparisons between ADHD core symptoms, school performance, age, IQ, and sociodemographic characteristics between the three experimental groups before treatments began

Dropouts

After randomization of 130 participants, a total of 39 children (30%) “dropped out” before or during the treatment.Citation20 Before treatment started 29 participants (ten, eleven, and eight patients from groups 1–3, respectively) “dropped out” due to parental lack of interest, loss of child/adolescent motivation, or other practical reasons such as difficulties and costs of transportation, family situation. During treatment, a further ten participants (three, three, and four patients from groups 1–3, respectively) “dropped out” with no reason given. For the 91 participants completing treatment, eleven participants did not complete the SRQ (four, four, and three from groups 1–3, respectively). Of these 80 participants who completed SRQ, three of them missed the question concerning ADHD core symptoms (77) and additionally four participants did not answer on school performance (73). However, post-randomization analyses found the balance for variables age, sex, IQ, comorbidity, and socio-demography between the “dropouts” and treatment groups.

Treatment groups

Baseline properties of the study sample are given in . None of the characteristics (age, sex, IQ, and ADHD symptoms) was significantly different between the treatment groups (P>0.01), although differences in hyperactivity baseline scores almost reached significance (P=0.011). The three groups were comparable with regard to sociodemographic characteristics, including family constellation, siblings, parent education, economic factors, and other means of support such as child welfare and special school support.

Evaluation of pre–post changes

Pre–post changes and results of the GLM estimation are given in . We found a significant improvement in SRQ score for both attention (P<0.001) and hyperactivity (P=0.001) without adjustments. The effect sizes for all groups were positive. The significant pre–post changes disappeared after adjustment for age and sex.

Table 2 ADHD core symptoms (attention, hyperactivity, total score) regarding the treatments (NF, MED, combined) reported from children and adolescents

For school achievement, the GLM analysis did not reveal any significant change in SRQ score after treatment (P=0.568, unadjusted). Note however, that school performance in the NF group did show a significant improvement (mean difference 1.5; 95% confidence interval [CI] 0.1 to 0.29).

Evaluation of treatment effect

Treatment effect was defined as the score difference between the treatment groups. We observed a significant effect of treatment on school performance (P=0.04), but not for hyperactivity (P=0.9) or attention (P=0.7) using the unadjusted model (). Similar results were obtained from the adjusted model. As seen in the results of the pre–post analysis, the NF group reported significant improvement in school performance (CI: NF, 0.1 to 2.9); the other groups did not (CI: MPH, −1.2 to 1.4; NF/MPH, −2.3 to 0.3).

Table 3 Characteristics of 130 randomized participants in the neurofeedback treatment study of ADHD children and adolescents

School performance, tested by one-sample t-test (if the change score equals 0), increased for the NF group significantly regarding writing (P=0.04) and calculation (P=0.05). The MED group reported a significantly increased performance in calculation (P=0.03).

Correlation between the participants and parents

The two core symptoms of ADHD reported by parents were addressed in an earlier study.Citation32 We did not find significant correlations between the reports from children and parents for any domain at a 5% level. The same pattern of correlation was found for both time points (T1 and T2).

Discussion

The present study randomly assigned ADHD children and adolescents to active control and two experimental groups evaluating NF with self-reports. Shortly after treatment participants in all three groups reported improvement in ADHD core symptoms, with no significant differences in ADHD symptoms between the groups.

Previous studies have seldom discussed self-reports in conjunction with NF treatment in young people with ADHD. While most studies have confirmed the difficulties in self-report design studies, they also express the importance of self-reporting in ADHD children and adolescents.Citation27,Citation44Citation46 In addition, considerable variation has been observed depending on the type of questions used for assessment.Citation47 In the present study we wanted to explore the changes from one time to another using the same questions for the same participant and therefore we found it reasonable to compose a short form to make sure that as many participants as possible were able to complete the SRQ. This was accomplished in the present study for more than four in five participants.Citation32,Citation48

Children reported similar effects in all three measured factors across the three treatment groups. Other studies have also reported that clinical improvements in core ADHD symptoms after NF and stimulant medication were on par with each other.Citation8,Citation49,Citation50 Indeed, NF and MPH were correspondingly effective in treating core ADHD symptoms in two separate groups.Citation7 However, no significant pre–post changes in any groups after adjusting for age and sex have been found. The lack of a significant difference after adjusting for confounding factors was probably due to the small sample size, and a lack of power in the study with additional variables. Further, it is important to emphasize that the changes reported here were evident only 1 week after treatment completion which can be a bias, thus, longer follow-up is needed.

NF effect in randomized studies demonstrated a lower effect size (ES) for hyperactivity, suggesting that hyperactivity is probably most sensitive to non-specific treatment factors (eg, time spent with a therapist), which is not in accordance with non-randomized studies.Citation16,Citation18,Citation39,Citation40,Citation51Citation53 Moriyama et al concluded in a review that non-randomized controlled trials found medium-to-large ESs, while the evidence for an NF effect in randomized controlled studies was considered more resilient.Citation12 Still, there is no available data on optimal treatment protocols or to guide clinicians on predictors of NF response.

The impact of non-specific factors, such as parental support and/or cognitive training during NF treatment has been evaluated.Citation18,Citation54 Those studies concluded that the patient-therapist interaction and the time spent with the therapist in a structured learning environment may contribute to a positive behavioral effect reported in NF treatment.Citation54 NF sessions are thought to be a form of “cognitive training”, as the therapist and patient interact, meet regularly, and spend time together. Evaluation of cognitive training activities may have positive implications on NF treatment results, as they may support the learning process, augmenting results. Arns et al has suggested that hyperactivity could be more easily influenced by non-specific effects than inattention and impulsivity.Citation18 Moreover, parental support, including simply transporting participants to and from the place of treatment, is also of importance when evaluating the NF effect.

Reported levels of school performance were higher in the NF group, which seems to be in accordance with results reported by Gaddes and Edgell.Citation55 They reported improvements in academic performance in 80% of ADHD children who were treated with NF.Citation55 Cognitive improvements in children with ADHD have been reported after NF treatment from Leins et al.Citation57 Fernandez et al also found increased cognitive and academic/school performance in children with learning disabilities after the NF treatment and explained it as a consequence of changes in brain activity during the treatment.Citation56 The effect of self-regulation on cognitive and academic performance has also been described by Strehl et al after NF treatment with SCP.Citation48

It is interesting that NF alone, but not in combination with medication, influences school performance. The simple explanation may be personal and subjective perception of the effectiveness by making improvements in you alone and with own means and effort. Or, one can guess whether improved cognitive functions or the transferring of learning process which the child is exposed to during the treatment, may influence or improve school performance. NF is a learning process to regulate one’s own brain activity.Citation48 Also, because it is a learning process, it has to be repeated in order to enhance the skills. School performance will improve once this has been achieved, and will most often be maintained.

However, influence of change in parental style throughout the NF treatment as well as parents’ expectations and satisfaction with the treatment, such as reported by Leins et al might have affected the behavior and school performance and therefore confounded outcome variables.Citation57

The strengths of the present study are the randomized design, use of ICD-10 diagnostics with a multi-domain diagnostic assessment, and a follow-up rate that is reasonable for ADHD studies. Previous studies have seldom included a control randomization, and therefore evidence of NF effect has been interpreted with precaution.Citation8,Citation19,Citation22,Citation47,Citation48,Citation58Citation60 As the randomization process is often demanding in order to fulfill all requirements, it often extends the study period.

A control group with stimulant medication was assigned in accordance with earlier studies.Citation7,Citation8,Citation16 We also tried to establish a placebo control group using “sham” treatment. During the pilot period, the NF sham placebo was found unfeasible due to difficulties for the therapist to adjust feedback parameters and placebo conditions. In addition, this placebo treatment was not ethically approved in the present thesis, which Logemann et al has also addressed.Citation61

There is no well-established standard NF treatment protocol, which presented a challenge to this study. In Lofthouse et al’sCitation62 review they found that two in three studies have used unipolar electrodes with a Cz placement equivalent to the present study.Citation12,Citation19 They found a variety of session numbers (20–40), and a variety of treatment durations (30–60 min), frequency (1–5 times/week), and course durations (2–20 weeks) for NF treatment in different studies.Citation8,Citation16,Citation62 To our knowledge, there is no existing consensus on standard methods regarding recommended number and frequency of sessions and standard placement of NF screening.Citation19,Citation62 Summarizing previous literature, 30 sessions, three times per week for 11–13 weeks using Cz unipolar placement was regarded as a “recommended” protocol, and therefore used in the present study. Furthermore, it remains unclear whether the theta/beta protocol represents an “optimal” training protocol for ADHD patients or whether other NF protocols may prove more effective.

Conclusion

The present study indicated that children and adolescents with ADHD experienced effects of NF, reported after 1 week. NF seemed to be promising as an alternative treatment given that almost a third of all children diagnosed with ADHD have complications or side effects from medication. Furthermore, while many parents oppose stimulant-based treatments on principle, they are likely to approve of NF. Long-term studies are needed to confirm these results.

Acknowledgments

We would like to thank all of the children and adolescents who participated in this study. This work was supported by the Department for Research, Helse Fonna Hospital, Norway under Grant 40411. We are grateful to Dr Doris Gundersen and Edanz Editing group for support in proofreading of the manuscript. We are grateful for valuable support and contributions regarding NF to Dr Tanju Surmeli, BCIA-C, board member of EEG and Clinical Neuroscience Society. The project was further supported by the National Competence Center for AD/HD, Tourette syndrome and Narcolepsy, Norway. We also thank the staff at the Child and Adolescent Mental Health Clinic, Helse Fonna Hospital for their support completing this study and collecting the data.

Supplementary material

Self-report questionnaire (SRQ)

Disclosure

The authors hereby declare that there are no financial or non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) in relation to this manuscript.

References

  • DaleyKCUpdate on attention-deficit/hyperactivity disorderCurr Opin Pediatr200416221722615021207
  • SwansonJMSergeantJATaylorESonuga-BarkeEJJensenPSCantwellDPAttention-deficit hyperactivity disorder and hyperkinetic disorderLancet199835191004294339482319
  • BarkleyRAAttention-deficit hyperactivity disorder: A handbood for diagnosis and treatment2nd edNew YorkGuilford Press1998
  • ThompsonLThompsonMNeurofeedback Intervention for Adults with ADHDJournal of Adult Development2005122–3123130
  • GruzelierJEgnerTCritical validation studies of neurofeedbackChild Adolesc Psychiatr Clin N Am20051418310415564053
  • LubarJFNeocortical dynamics: implications for understanding the role of neurofeedback and related techniques for the enhancement of attentionAppl Psychophysiol Biofeedback19972221111269341967
  • FuchsTBirbaumerNLutzenbergerWGruzelierJHKaiserJNeurofeedback treatment for attention-deficit/hyperactivity disorder in children: a comparison with methylphenidateAppl Psychophysiol Biofeedback200328111212737092
  • RossiterTThe effectiveness of neurofeedback and stimulant drugs in treating AD/HD: part II. ReplicationAppl Psychophysiol Biofeedback200429423324315707253
  • SherlinLArnsMLubarJSokhadzeEA position paper on neurofeedback for the Treatment of ADHDJ Neurother20101426678
  • ArnsMHeinrichHStrehlUEvaluation of neurofeedback in ADHD: The long and winding roadBiol Psychol20149510811524321363
  • HeinrichHGevenslebenHStrehlUAnnotation: neurofeedback – train your brain to train behaviourJ Child Psychol Psychiatry200748131617244266
  • MoriyamaTSPolanczykGCayeABanaschewskiTBrandeisDRohdeLAEvidence-based information on the clinical use of neurofeedback for ADHDNeurotherapeutics20129358859822930416
  • GevenslebenHRothenbergerAMollGHHeinrichHNeurofeedback in children with ADHD: validation and challengesExpert Rev Neurother201212444746022449216
  • ButnikSMNeurofeedback in adolescents and adults with attention deficit hyperactivity disorderJ Clin Psychol200561562162515723361
  • FrielPNEEG Biofeedback in the Treatment of Attention Deficit/HyperactivityAltern Med Rev200712214615117604459
  • MonastraVJMonastraDMGeorgeSThe effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorderAppl Psychophysiol Biofeedback200227423124912557451
  • MonastraVJLubarJFLindenMThe development of a quantitative electroencephalographic scanning process for attention deficit- hyperactivity disorder: reliability and validity studiesNeuropsychology200115113614411216884
  • ArnsMde RidderSStrehlUBretelerMCoenenAEfficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysisClin EEG Neurosci200940318018919715181
  • LofthouseNArnoldLEHerschSHurtEDeBeusRA review of neurofeedback treatment for pediatric ADHDJ Atten Disord201216535137222090396
  • DuricNSAssmusJGundersenDElgenIBNeurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reportsBMC Psychiatry20121210722877086
  • MeiselVServeraMGarcia-BandaGCardoEMorenoINeurofeedback and standard pharmacological intervention in ADHD: A randomized controlled trial with six-month follow-upBiol Psychol2013941122123665196
  • LansbergenMMvan Dongen-BoomsmaMBuitelaarJKSlaats-WillemseDADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility studyJ Neural Transm2011118227528421165661
  • Sonuga-BarkeEJBrandeisDCorteseSNonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatmentsAm J Psychiatry2013170327528923360949
  • LaubMvan LeeuwenSPGLogemann-MolnárZThe effect of Neurofeedback training on healthy individuals as measured by objective and self report measures of attention and impulsivity, when compared to a sham control condition [master’s thesis]Universitet Utrecht2008
  • YoungSGudjonssonGMischPPrevalence of ADHD symptoms among youth in a secure facility: the consistency and accuracy of self-and informant-report ratingsThe Journal of Forensic Psychiatry and Psychology2010212238246
  • RileyAWEvidence that school-age children can self-report on their healthAmbul Pediatr200444 Suppl37137615264962
  • RizzoPSteinhausenHCDrechslerRSelf-perception of self-regulatory skills in children with attention-deficit/hyperactivity disorder aged 8–10 yearsAtten Defic Hyperact Disord20102417118321432604
  • BellLKellisonIGarvanCWBussingRRelationships between child-reported activity level and task orientation and parental attention-deficit/hyperactivity disorder symptom ratingsJ Dev Behav Pediatr201031323323720410701
  • JensenPSRubio-StipecMCaninoGParent and child contributions to diagnosis of mental disorder: are both informants always necessary?J Am Acad Child Adolesc Psychiatry199938121569157910596258
  • HozaBGerdesACHinshawSPSelf-perceptions of competence in children with ADHD and comparison childrenJ Consult Clin Psychol200472338239115279522
  • EvangelistaNMOwensJSGoldenCMPelhamWEJrThe positive illusory bias: do inflated self-perceptions in children with ADHD generalize to perceptions of others?J Abnorm Child Psychol200836577979118188536
  • OwensJSGoldfineMEEvangelistaNMHozaBKaiserNMA critical review of self-perceptions and the positive illusory bias in children with ADHDClin Child Fam Psychol Rev200710433535117902055
  • EiserCMorseRThe measurement of quality of life in children: past and future perspectivesJ Dev Behav Pediatr200122424825611530898
  • WatersEStewart-BrownSFitzpatrickRAgreement between adolescent self-report and parent reports of health and well-being: results of an epidemiological studyChild Care Health Dev200329650150914616908
  • DuricNSElgenICharacteristics of Norwegian children suffering from ADHD symptoms: ADHD and primary health carePsychiatry Res2011188340240521621851
  • DuricNSElgenINorwegian Children and Adolescents with ADHD – A Retrospective Clinical Study: Subtypes and Comorbid Conditions and Aspects of Cognitive Performance and Social SkillsAdolescent Psychiatry201114349354
  • WechslerDManual for the Wechsler Intelligence Scale for ChildrenNew YorkPsychological Corporation1949
  • World Health OrganizationInternational Statistical Classification of Diseases and Related Health Problems 10th RevisionWorld Health Organization1992
  • LubarJFLubarJONeurofeedback Assessment and Treatment for Attention Deficit/Hyperactivity DisordersIntroduction to Quantitative EEG and NeurofeedbackNew YorkAcademic Press1999
  • LubarJFSwartwoodMOSwartwoodJNO’DonnellPHEvaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performanceBiofeedback Self-Regul199520183997786929
  • MillerHAHarrisonDCBiomedical Electrode TechnologyNew YorkAcademic Press1974
  • PiersEVHarrisDBHerzbergDSPiers-Harris Children’s Self-Concept Scale, Second Edition (Piers-Harris 2)Los AngelesWestern Psychological Services2001
  • MorrisSBDeShonRPCombining effect size estimates in meta-analysis with repeated measures and independent-groups designsPsychol Methods20027110512511928886
  • Curko KeraEAMarksDJBerwidOGSantraAHalperinJMSelf-report and objective measures of ADHD-related behaviors in parents of preschool children at risk for ADHDCNS Spectr20049963964715337861
  • HouckGKendallJMillerAMorrellPWiebeGSelf-concept in children and adolescents with attention deficit hyperactivity disorderJ Pediatr Nurs201126323924721601148
  • NashJKTreatment of attention deficit hyperactivity disorder with neurotherapyClin Electroencephalogr2000311303710638350
  • Pop-JordanovaNMarkovska-SimoskaSZorcecTNeurofeedback treatment of children with attention deficit hyperactivity disorderPrilozi2005261718016118616
  • StrehlULeinsUGothGKlingerCHinterbergerTBirbaumerNSelf-regulation of slow cortical potentials: a new treatment for children with attention-deficit/hyperactivity disorderPediatrics20061185e1530e154017060480
  • RossiterTRLaVaqueTJA Comparison of EEG biofeedback and psychostimulants in treating attention deficit/hyperactivity disordersJournal of Neurotherapy199514859
  • LindenMHabibTRadojevicVA controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilitiesBiofeedback Self Regul199621135498833315
  • BakhshayeshARDie Wirksamkeit von Neurofeedback im Vergleich zum EMG Biofeedbackbei der Behandlung von ADHS-Kindern. [The effectiveness of neurofeedback in comparison to EMG Biofeedback in the treatment of ADHD children]PhD thesisUniversität PotsdamGermany2007
  • GevenslebenHHollBAlbrechtBIs neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trialJ Child Psychol Psychiatry200950778078919207632
  • ThompsonLThompsonMNeurofeedback combined with training in metacognitive strategies: effectiveness in students with ADDAppl Psychophysiol Biofeedback199823424326310457815
  • BakhshayeshARHanschSWyschkonARezaiMJEsserGNeurofeedback in ADHD: a single-blind randomized controlled trialEur Child Adolesc Psychiatry201120948149121842168
  • GaddesWHEdgellDLearning Difficulties and Brain FunctionsNew YorkSpringer-Verlag1994
  • FernándezTHerreraWHarmonyTEEG and behavioral changes following neurofeedback treatment in learning disabled childrenClin Electroencephalogr200334314515214521276
  • LeinsUGothGHinterbergerTKlingerCRumpfNStrehlUNeurofeedback for children with ADHD: a comparison of SCP and Theta/Beta protocolsAppl Psychophysiol Biofeedback2007322738817356905
  • MonastraVJLynnSLindenMLubarJFGruzelierJLaVaqueTJElectroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorderAppl Psychophysiol Biofeedback20053029511416013783
  • GevenslebenHHollBAlbrechtBNeurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trialEur Child Adolesc Psychiatry201019971572420499120
  • StjernholmONeurofeedback as ADDH therapyUgeskr Laeger20101723322212225 Danish20727288
  • LogemannHNLansbergenMMVan OsTWBockerKBKenemansJLThe effectiveness of EEG-feedback on attention, impulsivity and EEG: a sham feedback controlled studyNeurosci Lett20104791495320478360
  • LofthouseNArnoldLEHurtECurrent status of neurofeedback for attention-deficit/hyperactivity disorderCurr Psychiatry Rep201214553654222890816